Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leukine in active Crohn's disease
NCT00295165Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jan 2006
- Primary completion
- Oct 2006
- Countries
- 11
01
Overview
A Phase 3 trial of sargramostim in Crohn's disease, sponsored by Sanofi. Started Jan 2006; status: terminated.
02
Drugs
sargramostim
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00295165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295165.